Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.

Co-located with our

COMMERCIAL EXCELLENCE SUMMIT

eyeforpharma Japan 2018 Real World Evidence 11th Annual|May 16-17, 2018

New Real World Data (RWD) sources provide an unprecedented opportunity for Japanese companies to find, demonstrate and communicate their real value to patients, healthcare and society. 2018 is an important year, a turning point for Japan’s pharma industry, as the government and the industry encourage a rapid move towards increased use of Real World Evidence (RWE) from April 2018. As RWE moves from a niche topic into a strategic imperative demanded by the smartest senior executives, eyeforpharma’s in-depth conference has been redesigned to cover all of the key issues – and foster real progress in Japanese healthcare.

Key topics to be discussed:

  • The floodgates are opening: appreciate the opportunities that new RWE insights will bring
  • Access to the real world: a comprehensive review of the newest data sources which could support your strategy
  • Make it happen: arm your team with data science competencies and the latest technologies
  • A fundamental part of your strategy: see how RWE data-flow can revolutionize different functions 
  • Improve the trajectory and influence of your company in a value-based health economy

Pre-order the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown

The unrivalled speaker line-up for 2018

Yasuyuki Katayama
Yasuyuki Katayama

Corporate Officer, Country Medical Director and Head of Medical Japan

Pfizer Japan Inc.

Hiroyuki Kobayashi
Hiroyuki Kobayashi

Chief Medical Officer Japan/Asia, Medical Headquarters

Eisai Co., Ltd.

Makoto Suematsu
Makoto Suematsu

President

Japan Agency for Medical Research and Development

Hiroaki Miyata
Hiroaki Miyata

Professor, Department of Health Policy and Management School of Medicine

Keio University

Susumu Amano
Susumu Amano

Director, Market Access & External Relations

AbbVie GK

Jovelle Fernandez
Jovelle Fernandez

Vice President, Japan Medical Officer and Head, Japan Medical Affairs, Japan Pharma Business Unit

Takeda Pharmaceutical Company Limited

Kotonari Aoki
Kotonari Aoki

Department Manager, Real World Data Schience Dept.

Chugai Pharmaceutical Co.,Ltd.

Nariaki Yoshihara
Nariaki Yoshihara

Head of Health Economics & Outcomes Research, Market Access, Health Economics & Outcomes Research 

Bayer Yakuhin, Ltd.

Why attend eyeforpharma's Real World Evidence Summit Japan 2018

Collaborate:

Establish better relationships with key industry leaders and innovators

Network:

400+ colleagues, comprehensive exhibition area and drink receptions

Learn:

20+ expert speakers, industry-driven agenda, panel discussion and workshops

Pre-order the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown